| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 02/23/2006 | US20060040956 Substituted alkylamine derivatives and methods of use |
| 02/23/2006 | US20060040950 Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists |
| 02/23/2006 | US20060040949 Treating antibiotic resistant bacterial infections; compounds based on quinoline rings; (3S)-2-(3-{[(Benzo[1,2,5]thiadiazol-5-ylmethyl)-amino]-methyl}-piperidin-1-yl)-(1RS)-(6-methoxy-quinolin-4-yl)-ethanol for example |
| 02/23/2006 | US20060040937 N-aroyl cyclic amines as orexin receptor antagonists |
| 02/23/2006 | US20060040927 Heterocyclic antiviral compounds |
| 02/23/2006 | US20060040918 Benzo d!azepine derivatives for the treatment of neurological disorders |
| 02/23/2006 | US20060040906 Piperazine urea derivatives as melanocortin-4 receptor agonists |
| 02/23/2006 | CA2581327A1 Intracellular receptor modulator compounds and methods |
| 02/23/2006 | CA2577668A1 Novel antidiabetic compounds |
| 02/23/2006 | CA2577060A1 Substituted benzofused heterocycles |
| 02/23/2006 | CA2576599A1 Substituted hydantoins |
| 02/23/2006 | CA2575853A1 Isoindolone compounds and their use as metabotropic glutamate receptor potentiators |
| 02/23/2006 | CA2575785A1 5-ht7 receptor antagonists |
| 02/23/2006 | CA2575771A1 5-ht7 receptor antagonists |
| 02/23/2006 | CA2575561A1 Amido compounds and their use as pharmaceuticals |
| 02/23/2006 | CA2574156A1 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 02/23/2006 | CA2573819A1 Heterocyclic dye compounds for in vivo imaging and diagnosis of alzheimer's disease |
| 02/23/2006 | CA2573772A1 Heterocyclyls as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders |
| 02/23/2006 | CA2573764A1 Hydantoin derivatives for the treatment of inflammatory disorders |
| 02/23/2006 | CA2573714A1 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 02/23/2006 | CA2567782A1 Heterocyclic condensed compounds useful as antidiuretic agents |
| 02/22/2006 | EP1627876A1 Heterocyclic condensed compounds useful as antidiuretic agents |
| 02/22/2006 | EP1627875A1 Method for producing cyclic diamine derivative or salt thereof |
| 02/22/2006 | EP1627873A1 Benzofuran compound and medicinal composition containing the same |
| 02/22/2006 | EP1627869A1 Amide derivative |
| 02/22/2006 | EP1626965A1 Pyrazinones as crf1 receptor antagonists for the treatment of cns disorders |
| 02/22/2006 | EP1626964A2 New benzimidazole derivatives |
| 02/22/2006 | EP1626960A1 Diarylmethylidene piperidine derivatives and their use as delta opioid receptor agonists |
| 02/22/2006 | EP1441735B1 N-substituted hydroxypyrimidinone carboxamide inhibitors of hiv integrase |
| 02/22/2006 | EP1385839B1 3-substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 02/22/2006 | CN1738814A Indolyl pyrazinone derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| 02/22/2006 | CN1738808A Cyclization process for substituted benzothiazole derivatives |
| 02/22/2006 | CN1738805A N- (1-benzyl-2-oxo-2- (1-piperazinyl) ethyl) -1-piperidincarboxamid-derivatives and related compounds use as CGRP-antagonists for treating a headache |
| 02/22/2006 | CN1738804A 吡唑化合物 Pyrazole compounds |
| 02/22/2006 | CN1738801A Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 02/22/2006 | CN1738798A Indole derivatives as somatostatin agonists or antagonists |
| 02/22/2006 | CN1738797A Substituted aryl thioureas and related compounds; inhibitors of viral replication |
| 02/22/2006 | CN1738618A Pharmaceutical compositions and their uses |
| 02/22/2006 | CN1242995C Novel compounds, their use and preparation |
| 02/22/2006 | CN1242994C Novel heterocyclic compound and medicinal use thereof |
| 02/21/2006 | US7002020 Oxazolidinone combinatorial libraries, compositions and methods of preparation |
| 02/21/2006 | US7002019 aryl hydrocarbon; oxidation of 4,5-dihydro-1,3-azoles to fully unsaturated ring; heterocyclic ketones |
| 02/21/2006 | US7001917 2-(4-(4-(4-Fluorophenyl)-3,5-imethyl-1H-pyrazol-1-yl)phenyl) ethyl (4-methylphenyl)sulfonylcarbamate ammonium salt, e.g., as an antagonist for Prostoglandin E receptor; analgesics; antipyretics; antiinflammatory agents |
| 02/21/2006 | US7001916 Epothilon derivatives, method for the production and the use thereof as pharmaceuticals |
| 02/21/2006 | US7001910 substituted pyrimidinyl-amino-ethoxy benzyl-thiazolidine-diones; hypoglycemic agents |
| 02/21/2006 | US7001909 For therapy of cardiovascular diseases such as atrial and ventricular arrhythmias, intermittent claudication, Prinzmetal's (variant) angina, stable and unstable angina, exercise induced angina, congestive heart disease |
| 02/21/2006 | US7001905 Substituted diarylamines as MEK inhibitors |
| 02/21/2006 | US7001899 7-member ring N-heterocycles that have a cysteine trap substitution; treating osteoarthritis |
| 02/21/2006 | CA2337846C Polymorph of ritonavir |
| 02/16/2006 | WO2006017761A2 Epothilone analogues as therapeutic agents |
| 02/16/2006 | WO2006016725A1 Photosensitive heterocyclic azo compound, process for producing the same, and optical information recording medium |
| 02/16/2006 | WO2006016637A1 Novel cyclic aminobenzoic acid derivative |
| 02/16/2006 | WO2006016178A1 Enantioselective process |
| 02/16/2006 | WO2006016174A1 Fluorination process of protected aminothiazole |
| 02/16/2006 | WO2006016067A2 Pyrido-pyrido pyrimidine derivatives, preparation thereof, therapeutic use thereof for treating cancer |
| 02/16/2006 | WO2006016039A1 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof |
| 02/16/2006 | WO2006015854A2 Azetidine derivatives as ccr-3 receptor antagonists |
| 02/16/2006 | WO2005097137A3 Advanced quinazoline based protein kinase inhibitors |
| 02/16/2006 | WO2005082900A3 Oxazolidinone amidoximes as antibacterial agents |
| 02/16/2006 | WO2005079378A3 Synthetic techniques and intermediates for polyhydroxy dienyl lactones and mimics thereof |
| 02/16/2006 | WO2005055941A3 Novel m3 muscarinic acetylcholine receptor antagonists |
| 02/16/2006 | US20060036098 Carbonylamino-benzimidazole derivatives as androgen receptor modulators |
| 02/16/2006 | US20060035946 Amyloid-binding, metal-chelating agents |
| 02/16/2006 | US20060035945 Prevent reproduction, infection of virus; antitumor agents |
| 02/16/2006 | US20060035935 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 02/16/2006 | US20060035916 2,4-Pyrimidinediamine compounds and their uses |
| 02/16/2006 | US20060035899 Use of cysteine derivatives for the preparation of a medicament intended to treat pathologies which result from the formation of the heterotrimeric G protein |
| 02/16/2006 | US20060035895 Isoxazoline derivatives useful as antimicrobials |
| 02/16/2006 | US20060035171 Capable of high-speed recording; zinc (divalent) as a center metal ion and an azo compound bonded with a coupler component having an amino group and a fluorine-substituted alkylsulfonylamino group subjected to condensed ring-formation to have a 1,3,4-thiazole ring as a diazo component |
| 02/16/2006 | US20060034832 Cell death inhibitor |
| 02/16/2006 | CA2575039A1 Novel cyclic amino benzoic acid derivative |
| 02/16/2006 | CA2574827A1 4-piperazinyl-pyrimidine compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 02/16/2006 | CA2572748A1 Organic compounds |
| 02/16/2006 | CA2572614A1 Pyrido-pyrido pyrimidine derivatives, preparation thereof, therapeutic use thereof for treating cancer |
| 02/16/2006 | CA2571143A1 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof |
| 02/15/2006 | EP1625125A1 Compounds as crf1 receptor antagonists |
| 02/15/2006 | EP1625121A1 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 02/15/2006 | EP1625120A1 Chemical compounds |
| 02/15/2006 | CN1735612A Anti-infective agents |
| 02/15/2006 | CN1735611A CB 1 receptor inverse agonists |
| 02/15/2006 | CN1735607A 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (PI) 3-kinase inhibitors and their use in the treatment of cancer |
| 02/15/2006 | CN1735605A Phenylalanine derivatives as depeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 02/15/2006 | CN1735596A Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 02/15/2006 | CN1735595A Substituted alkyl amido piperidines |
| 02/15/2006 | CN1735592A Hydroxyethylamine derivatives for the treatment of alzheimer's disease |
| 02/15/2006 | CN1733725A Process for preparing 2-iminopyrrolidine derivatives |
| 02/15/2006 | CN1733723A Indole and dihydroindole derivatives |
| 02/14/2006 | US6998416 Cyclic AMP-specific phosphodiesterase inhibitors |
| 02/14/2006 | US6998412 Heterocyclic compounds |
| 02/14/2006 | US6998407 For prophylaxis and therapy of chronic or acute inflammatory or autoimmune diseases, those associated with aberrant lymphocyte or monocyte accumulation such as arthritis, asthma, atherosclerosis, diabetic nephropathy, inflammatory bowel disease |
| 02/14/2006 | US6998256 Methods of obtaining epothilone D using crystallization and /or by the culture of cells in the presence of methyl oleate |
| 02/14/2006 | CA2241186C Benzimidazole derivatives |
| 02/14/2006 | CA2218945C 4-aminoquinazoline derivatives |
| 02/14/2006 | CA2192645C Tri-substituted phenyl derivatives useful as pde iv inhibitors |
| 02/14/2006 | CA2192644C Tri-substituted phenyl derivatives useful as pde iv inhibitors |
| 02/14/2006 | CA2192643C Tri-substituted phenyl derivatives useful as pde iv inhibitors |
| 02/14/2006 | CA2180155C Naphthylamides as central nervous system agents |
| 02/14/2006 | CA2105666C New centrally acting substituted phenylazacycloalkanes |
| 02/09/2006 | WO2006015004A2 White light-emitting electroluminescent device |
| 02/09/2006 | WO2006014290A2 Anti-inflammatory medicaments |